Injection pain and postinjection pain of the palatal-anterior superior alveolar injection, administered with the Wand Plus system, comparing 2% lidocaine with 1:100,000 epinephrine to 3% mepivacaine.
D000328:Adult; D000766:Anesthesia, Dental / Q000009:adverse effects / Q000295:instrumentation*; D000779:Anesthetics, Local / Q000008:administration & dosage*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004837:Epinephrine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006987:Hypesthesia / Q000209:etiology; D007180:Incisor / Q000294:innervation; D007267:Injections / Q000009:adverse effects / Q000295:instrumentation; D008012:Lidocaine / Q000008:administration & dosage*; D008297:Male; D008619:Mepivacaine / Q000008:administration & dosage*; D008875:Middle Aged; D009339:Needles / Q000009:adverse effects; D009407:Nerve Block / Q000009:adverse effects / Q000295:instrumentation*; D010146:Pain / Q000209:etiology*; D010147:Pain Measurement; D010919:Placebos; D011446:Prospective Studies; D014662:Vasoconstrictor Agents / Q000008:administration & dosage
D000779:Anesthetics, Local; D010919:Placebos; D014662:Vasoconstrictor Agents; D008012:Lidocaine; D008619:Mepivacaine; D004837:Epinephrine